Osaic Holdings
SRRA

Osaic Holdings’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Osaic Holdings’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-101
Closed -$3K – 7812
2022
Q1 		$3K Sell
101
-735
-88% -$21.1K ﹤0.01% 6830
2021
Q4 		$18K Sell
836
-23
-3% -$507 ﹤0.01% 5883
2021
Q3 		$19K Buy
859
+91
+12% +$1.82K ﹤0.01% 5836
2021
Q2 		$15K Buy
768
+655
+580% +$11.9K ﹤0.01% 5855
2021
Q1 		$2K Buy
+113
New +$1.79K ﹤0.01% 6565

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Osaic Holdings's SRRA Position: Q2 2022 in Review

Osaic Holdings sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 101 shares — an estimated $3K sold.

Osaic Holdings first reported a position in SRRA in Q1 2021 and held it in 5 quarters. The position peaked at $19K in Q3 2021. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

  • Osaic Holdings reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Osaic Holdings sold 101 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $3K.
  • Osaic Holdings first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Osaic Holdings's Sierra Oncology, Inc. Common Stock position peaked at $19K in Q3 2021.
  • 109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.